Q2 2025 Cresco Labs Inc Earnings Call Transcript
Key Points
- Cresco Labs Inc (CRLBF) delivered $164 million in revenue for Q2 2025, in line with guidance and consistent with Q1 levels.
- The company generated $83 million in adjusted gross profit and $41 million in adjusted EBITDA, showcasing efficiency gains.
- Cresco Labs Inc (CRLBF) signed a letter of commitment to refinance $325 million of its debt, extending the maturity date to 2030.
- The company is strategically exiting the California market to strengthen its margin profile and focus on more profitable markets.
- Cresco Labs Inc (CRLBF) is expanding its footprint with new dispensaries in Ohio and cultivation build-out in Kentucky, positioning for future growth.
- The company experienced a 1% sequential decline in revenue from Q1, primarily due to price compression in Illinois retail operations.
- Price compression remains a challenge across several markets, impacting revenue growth.
- Initial yields from new cultivation facilities are expected to drag on margins in Q3 and Q4.
- Cresco Labs Inc (CRLBF) is facing competitive pressures in core markets, requiring strategic adjustments.
- The company is dealing with credit risk in wholesale markets like Massachusetts and Illinois, impacting sales decisions.
Good day, and welcome to Cresco Labs second quarter 2025 earnings conference call. (Operator Instructions)
I would now like to turn the call over to TJ Cole, Senior Vice President, Corporate Development and Investor Relations for Cresco Labs. Please go ahead.
Thank you. Good morning, and welcome to Cresco Labs second quarter 2025 earnings conference call. On the call today, we have Chief Executive Officer and Co-Founder, Charles Bachtell; Chief Financial Officer, Sharon Schuler; and President, Greg Butler, who will be available through the Q&A.
Prior to this call, we issued our second-quarter earnings press release, which has been filed on SEDAR and is available on our Investor Relations website. These preliminary results for the second quarter are provided prior to completion of all internal and external reviews and therefore are subject to adjustment until the filing of our company's quarterly financial statements. We plan to file our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
